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Abstract
Background: Neural stem cells offer potential treatment for neurodegenerative disorders, such like Alzheimer’s
disease (AD). While much progress has been made in understanding neural stem cell function, a precise
description of the molecular mechanisms regulating neural stem cells is not yet established. This lack of knowledge
is a major barrier holding back the discovery of therapeutic uses of neural stem cells. In this paper, the regulatory
mechanism of mouse neural stem cell (NSC) differentiation by tmem59 is explored on the genome-level.
Results: We identified regulators of tmem59 during the differentiation of mouse NSCs from a compendium of
expression profiles. Based on the microarray experiment, we developed the parallelized SWNI algorithm to
reconstruct gene regulatory networks of mouse neural stem cells. From the inferred tmem59 related gene network
including 36 genes, pou6f1 was identified to regulate tmem59 significantly and might play an important role in the
differentiation of NSCs in mouse brain. There are four pathways shown in the gene network, indicating that
tmem59 locates in the downstream of the signalling pathway. The real-time RT-PCR results shown that the over-
expression of pou6f1 could significantly up-regulate tmem59 expression in C17.2 NSC line. 16 out of 36 predicted
genes in our constructed network have been reported to be AD-related, including Ace, aqp1, arrdc3, cd14, cd59a,
cds1, cldn1, cox8b, defb11, folr1, gdi2, mmp3, mgp, myrip, Ripk4, rnd3, and sncg. The localization of tmem59 related
genes and functional-related gene groups based on the Gene Ontology (GO) annotation was also identified.
Conclusions: Our findings suggest that the expression of tmem59 is an important factor contributing to AD. The
parallelized SWNI algorithm increased the efficiency of network reconstruction significantly. This study enables us to
highlight novel genes that may be involved in NSC differentiation and provides a shortcut to identifying genes for
AD.
Background
One of the main goals of systems biology is to determine
the biological networks by high performance computing
methods and integrating high-throughput data [1,2].
Compared to the traditional biology, which basic strategy
is to decypher biological functions by concentrating
efforts on a very limited set of molecules, this system-
centric approach has an enormous success in producing
complex biological networks composed of various types
of molecules (genes, proteins, MicroRNAs, etc) from
large amounts of data [3].
The microarray technology facilitates large-scale surveys
of gene expression data for whole-genome mapping and
gene expression analyzing under various conditions [4]. A
major focus on microarray data analysis is the reconstruc-
tion of gene regulatory networks, which aims to find new
gene functions and provide insights into the transcrip-
tional regulation that underlies biological processes [5]. A
wide variety of approaches have been proposed to infer
gene regulatory networks from microarray data. Those
approaches are based on different theories, including Boo-
lean networks [6], Bayesian networks [7], relevance net-
works [8], graphical models [9], genetic algorithm [10],
neural networks [11], controlled language-generating
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linear differential equations [14]. There are two difficulties
that can be addressed for constructing gene networks
from gene expression data. Firstly, a single set of gene
expression data contains a limited number of time-points
under a specific condition. Thus, the problem of determin-
ing gene regulatory network becomes an ill-posed one
which is difficult to overcome. In the second, while micro-
array experiments collect an increasing amount of data to
be correlated, the network reconstruction is an NP-hard
problem. Therefore, application of the statistical frame-
work to a large set of genes requires a prohibitive amount
of computing time on a single-CPU. A fundamental pro-
blem with the sequential algorithms is their limitation to
handle large data sets within a reasonable time and mem-
ory resources.
Neurodegenerative disorder, including Alzheimer’s dis-
ease (AD), Parkinson’s disease, and Huntington’s diseases
etc, is a progressive loss of neurons. Recently, transplan-
tation of NSCs within adult brain has been proposed as
one of the potential therapies for neurodegenerative dis-
orders [15]. NSCs are multipotent progenitor cells with
long-term, self-renewal and differentiation capabilities to
generate three major types of central nervous system
(CNS) cell: neurons, astrocytes and oligodendrocytes
[16]. They are identified as neuroepithelial cells extend-
ing from the ventricle to basal lamina of the pial surface
in the initial stage of brain development. During the his-
togenesis, radial glial stem cells divide asymmetrically to
neurons and give rise to astrocytes. Then NSCs become
neural progenitorcells existing in the adult brain neuro-
genic region: the sub-ventricular zone (SVZ) and the
sub-granular zone (SGZ) [17-20].
So far the stem cell therapy for neurodegenerative dis-
orders is still a challenging goal [21]. Mechanisms that
control the proliferation, differentiation, migration and
integration of NSCs are still poorly understood. Com-
prehensive the gene regulatory network corresponding
to NSCs by means of integrating and performing analy-
sis with efficient algorithms is a crucial part of systems
biology.
Moreover, mouse transmembrane protein 59 (TMEM59)
is an uncharacterized single transmembrane protein. Pre-
viously, our study in vitro suggested that TMEM59 is dif-
ferentially expressed during differentiation of primary
NSCs from Sprague-Dawley rat striatum [22]. Especially,
the down-regulation of TMEM59 with RNAi interference
in mouse C17.2 neural stem cell line increases the differen-
tiation of NSCs into neurons and astrocytes [23]. Our
study indicated that TMEM59 is related to the differentia-
tion and status sustaining of NSCs. So far the functions of
TMEM59 have not yet been reported. Exploration on the
tmem59 related gene regulation network of NSCs would
help us better understand the molecular mechanism
underlying the NSCs differentiation.
In this paper, we constructed gene regulatory networks
of mouse NSCs by the parallel strategy on stepwise net-
work inference method. By integrating our microarray
data and the public data, the regulatory mechanism of
mouse NSCs differentiation by tmem59 is explored
throughout the genome. The important pathways and
t h ec o r eg e n e ,pou6f1, are investigated by Real-time RT-
PCR, suggesting that the over-expression of pou6f1 sig-
nificantly up-regulated tmem59 expression. We also
show that many genes in the tmem59 related gene net-
work have been implicated in AD mechanism. The find-
ings enable us to highlightn o v e lg e n e st h a tm a yb e
involved in NSC differentiation and provides a shortcut
to identifying genes for AD.
Methods
Original data
Microarrays simultaneously quantify thousands of genes
on a single glass slide and their use has greatly expanded
the breadth of quantified gene expression [24]. In our
previous work, six wild and tmem59 knockout mice were
separately immersed in 75% alcohol for disinfection
[25,26]. Under aseptic conditions, the hippocampuses
were made into single cell suspension by mechanical
whipping. The supernatant was discarded after 900 rmp,
5 min centrifugation. Then the hippocampuses were
resuspended in medium (DMEM/F12 culture medium
with B27, EGF and bFGF) and were cultured in a glass
bottle in CO2 incubator (5% CO2, 37 degree). The gene
expression data were measured 4 days later. To under-
stand the biological functions of tmem59, we investigated
the genes that were differentially expressed due to
tmem59 knock out. From the tmem59 knock out micro-
array datasets, 627 genes that differentially expressed
with more than 2-fold change were selected as our source
of data (data not shown).
Significantly expressed genes selection
In order to focus on much significantly expressed genes
related to tmem59, we selected 80 genes for further ana-
lysis based on the Differential Ratio following tmem59
knock out. The precise description of the 80 genes with
functions is illustrated in Additional File 1: Table S1.
Public data selection
In order to examine the regulatory mechanism between
tmem59 and the corresponding genes, it is necessary to
integrate much more microarray data which can be
from either in-house or public domain. A good resource
for public microarray data is the National Institutes of
Health Gene Expression Omnibus http://www.ncbi.nlm.
Zhang et al. BMC Systems Biology 2011, 5:152
http://www.biomedcentral.com/1752-0509/5/152
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MIAME compliant and is selected from Gene Expres-
sion Omnibus (GEO).
Microarray data normalization
We transferred the probe data to standard gene expres-
sion data. Because a single gene is represented on the
array by typically a set of 11-20 pairs of probes, we
mapped probes to their corresponding Entrez GeneIDs.
Affymetrix probes were mapped to Entrez GeneIDs
using the 3 Sep 2010 release of NetAffx annotations.
Where probes had multiple GeneID mappings, the one
which appears at the top of the GeneID list was selected
because been observed that in the majority of such
cases the first identifier tends to be the only one with a
published symbol as opposed to one that was automati-
cally generated. We calculated the Average Difference
for all the probes of the corresponding gene to compare
the probe sets expression level of them. The higher the
probe set expressed, the larger Average Difference the
probes got. Then the expression levels in those probe
sets mapped to same gene was summarized. Probe
intensities from Affymetrix oligonucleotide microarrays
were normalized to gene expression levels using robust
multichip analysis (RMA) [27] which is reported to be
the single best normalization method compared to
MAS5 (Affymetrix), GCRMA, and Dchip PM [28]. The
use of ratios or raw intensities is governed by the cap-
abilities of the microarray technology, not by our
algorithm.
Parallelized SWNI Network inference algorithms
We designed and evaluated the Stepwise Network Infer-
ence (SWNI) algorithm in previous studies [29]. The
SWNI algorithm is a rapid and scalable method of
reconstructing gene regulatory networks using gene
expression measurements without any prior information
about gene functions or network structure. It solves
small size problem for high-dimensional data with strict
selections in the stepwise regression model. More pre-
cisely, the SWNI algorithm infers a module network in
two major stages. Firstly, the model is built with ordin-
ary differential equations to describe the dynamics of a
gene expression network in perturbation. Secondly, a
regression subset-selection strategy is adopted to choose
significant regulators for each gene. Moreover, statistical
hypothesis testing is used to evaluate the regression
model. Then the gene expression network with signifi-
cant edges and genes is predicted.
However, the SWNI algorithm is a sequential method
essentially. While dealing with a large set of genes, the
SWNI algorithm requires a prohibitive amount of com-
puting time. To overcome this extreme computational
requirement, in this study, we developed a parallel
implementation of the SWNI algorithm. Using the mes-
sage passing interface (MPI), the parallelized SWNI
algorithm has higher computing efficiency compared
with the SWNI method.
In this study, as same as our own microarray data, the
multiple datasets were selected from the experimental
platform GPL1261 and were normalized with the RMA
algorithm. We subsequently combined all the datasets
into a composite training set. The batch adjustment
algorithm was applied in the combined training set to
ensure that all the datasets were well intermixed [30].
The detail of the parallelized SWNI algorithm is as
follows.
A gene expression network is expressed by a set of
linear differential equations with each gene expression
level as variables, and we have
˙ X = AX + P,
where A =( aij)n×n is an n × n gene regulatory coeffi-
cient matrix, and refers to the connectivity of genes in
the predictive network; X is an n × m matrix referring
to the gene expression level at time t; P =( pij)n×m is a
matrix representing the external stimuli (like perturba-
tions) or environment conditions. The computational
complexity of the sequential SWNI algorithm is O(n
3).
In order to reduce the computational complexity, we
decomposed P by row to partition parallel tasks.
Assessment of the parallelized SWNI algorithm
Artificial gene networks with random scale-free struc-
ture were generated and the distribution of vertices fol-
lows a power law. The parallelized SWNI algorithm and
the SWNI algorithm have same computing precision.
The computing precision of the SWNI algorithm has
been discussed in [29]. And the performance of the
SWNI algorithm was assessed by comparing the inferred
network with the pre-determined artificial network.
The performance of the parallel strategy is evaluated
on the artificial gene networks in two important aspects,
which are speedup and efficiency. Compared with the
SWNI algorithm, the parallelized SWNI algorithm per-
formed better in efficiency. And as the number of pro-
cessors increases, we got almost linear speedups of the
parallelized SWNI algorithm.
RNA Isolation and Real-time RT-PCR analysis
To study the regulation of pou6f1 to tmem59 and quan-
tify mRNA by real-time RT-PCR in C17.2 NSCs, we used
ReverTra
® Ace qPCR RT kit and SYBR
® Green Realtime
PCR Master Mix (Toyobo Life Science Department).
For Neural stem cell line, C17.2 cells were plated onto
24-well plates at a density of 5 × 10
5 cells per well and
cultured at 37°C with 5% CO2 for 24 hours before
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were split. The murine cerebellum-derived immortalized
neural stem cell line C17.2 was originally described by
Snyder et al. [31].
Full-length cDNA fragment of Pou6f1 was then ampli-
fied by RT-PCR using total RNA from mouse brain.
The forward primer was 5’-GAAGATCTATGCCCGG-
GATC AGCAGTC-3’ and the reverse primer was 5’-
TCCGGAATTCCGGGATCTGAA AGACGTTC-3’. The
cDNA was further digested with Bgl II/EcoR Ia n ds u b -
cloned into pEGFP-N2 vector, ultimately sequenced by
Invitrogen. The total of 1 ug pEGFP-N2-Pou6f1 DNA
per well was used to transfect C17.2 cells using Lipofec-
tamine 2000 at a proportion of 1:1 (according to the
manufacturer’s protocol). C17.2 cells transfected with
pEGFP-N2 in the same condition were used as the con-
trol group.
Finally, the total RNA was isolated from each group
according to the Trizol manufacture’s standard protocol
(Takara Bio Inc). PCR primers for amplification of the
mouse tmem59 gene was specifically design (Invitrogen).
Chloroform and isopropanol were used to extract and
precipitate the total mRNA. RT-PCR analysis was per-
formed on a PE9700 PCR machine. All reactions were
repeated for three times. The relative quantity of tmem59
mRNA in the cells was calculated using the equation
RQ = 2
-ΔΔCt.T h eb-actin was used for normalization as
the internal control gene whereas the calibrator was the
mean threshold cycle (Ct) value for each control group
transfected with pEGFP-N2 vector. The forward primer
sequence for tmem59 gene is 5’-ATGCTTGTCAT
CTTGGCTG-3’ and the reverse primer sequence is 5’-
TCACTTCAGAACG ACCTCA-3’.T h ef o r w a r dp r i m e r
sequence for b-actin is 5’-TGTCCCTGTATGCCT and
the reverse primer sequence is 5’-TCACGCAC-
GATTTCCCTC-3’.
Statistical analysis
Statistical analysis and graph creation were performed
by SigmaStat3.5, SigmaPlot 10.0 and Pajek. Data were
obtained from at least three independent experiments.
Results were presented as means ± SEM. One-way
ANOVA was used to analyze the results of real-time
PCR. Proportion was analyzed by z-test, and Yates cor-
rection was applied to calculations.
Results
NSCs related microarrays are selected
We selected microarrays about NSCs, neurogenesis, glias
and central nervous system (CNS), due to that NSCs are
the principal source of constitutive neurogenesis and
glias in the CNS. 146 microarray datasets were selected
from 21 different platforms. The species, accession num-
bers, precise descriptions and number of data sets of the
21 platforms are illustrated in Additional File: Table S2.
The comparability of gene expression data generated
with different microarray platforms is still a matter of
concern. Mixing of data from various platforms could
lead to poor results due to quantitative biases among the
technologies [32]. Therefore, we selected the datasets
including only profiles from a single experimental plat-
form, which ID is identified as GPL1261 in GEO data-
base. In particular, we selected 62 mouse stem cell
related sample data sets for further analysis from the
Affymetrix Mouse Genome 430 2.0 arrays (Array
([Mouse430_2])), which includes approximately 45, 000
probe sets. The 62 mouse NSC related microarray data
sets included in the analysis are illustrated in Table 1.
The performance of the parallelized SWNI algorithm
Following the scale-free topology, we simulated two types
of artificial gene networks in size of 1000 nodes, 3054
edges, and 1500 nodes, 4630500 edges, respectively. The
performance of the parallelized SWNI algorithm was
assessed among the workstation described in the method.
Speedup and efficiency of the parallel SWNI algorithm
are illustrated in Figure 1, and the running time is shown
in Table 2. Figure 1 shows that as the increase of the net-
work scale, the parallelized SWNI algorithm performed
better in both efficiency and speedup. Table 2 shows
that, as increase in the processor numbers, the comput-
ing time of the algorithm falls dramatically. The results
demonstrated that the parallelized SWNI algorithm has
good performance on the artificial gene networks.
Gene regulatory networks of mouse neural stem cell
GRNs related to tmem59 were constructed on a compen-
dium of expression profiles by the parallelized SWNI
algorithm (Figure 2). As illustrated in Figure 2A, NSC-
GN1 contains 56 genes, 230 edges, and the average
degree is 4. From NSC-GN1, tmem59 is shown to be
negatively regulated by cd59, while positively regulated
by sncg. The global importance of a node in a network
c a nb ee v a l u a t e db yt h en o d ed e g r e eo fi t[ 3 3 ] .T h eb a s i c
evaluated strategy is that the bigger the degree of a node
is, or the closer to the centre of a network the node is,
the more important it is. According to this principle, in
N S C - G N 1t h e r ea r e2 2i m p o r t a n tn o d e s ,w h i c hh a v e
higher in-degree than the average degree, and can be
identified as: aqp1, calml4, cd59a, clic6, cxcl1, cyb561,
flvcr2, igfbpl1, lgals3bp, pou6f1, psmb8, s3-12, sncg
arrdc3, axud1, cds1, folr1, gpnmb, paqr9, ptprv, ripk4 and
slc35f3. Among the 22 nodes, there are 9 more important
nodes with twice in-degree than the average degree.
Those nodes are arrdc3, axud1, cds1, folr1, gpnmb,
paqr9, ptprv, ripk4 and slc35f3.
In order to focus on more significant genes, we rose
the significance level of the hypothesis testing in the
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Platform: GPL1261
Accession Type Samples Description
No.
GSE12499 NSCs 10 Oct4-Induced Pluripotency in Adult NSCs
GSE10806 Adult NSCs 11 Pluripotent SCs induced from adult NSCs by
reprogramming with two factors
GSE13379 CNSs 107 Application of a translational profiling approach for the
comparative analysis of CNS cell types
GSE11862 Neurogenesis 6 Early Gene expression changes after axonal injury
GSE10796 NPCs 4 Identification of genes that restrict astrocyte differentiation
of midgestational neural precursor cells
GSE11859 NPCs 27 Acquisition of granule neuron precursor identity and
Hedgehog-induced medulloblastoma in mice
GSE8034 Radial glias 17 Prospective isolation of functionally distinct radial glial
subtypes - lineage and transcriptome analysis
GSE8091 eNSCs 16 Embryonic brain development
GSE10577 Glia 12 endothelin signaling from photoreceptors to glia
GSE9812 NPCs 22 Molecular heterogeneity of developing retinal ganglion and
amacrine cells
GSE9763 NPCs 20 Transformed glial progenitor cells
GSE8555 eNSCs 8 D-3-phosphoglycerate dehydrogenase deficiency effect on
the embryonic head
GSE5817 eNSCs 21 understanding the process of cortical development
GDS2209 CNS 6 Spinal cord and dorsal root ganglion
GDS1017 CNS 15 Hypoxic-ischemic injury response to erythropoietin
pretreatment
GSE9811 NPCs 42 Individual retinal progenitor cells display extensive
heterogeneity of gene expression
GSE6675 Astroglia 8 Astroglial gene expression program elicited by
fibroblast growth factor-2 mande-affy-mouse-307080
GSE5425 CNS 6 Spinal cord and dorsal root ganglion
GSE5011 MSCs 10 molecular changes the MSC acquire through in-vitro
passages determine their therapeutic potential to EAE
GSE1999 Neurogenesis 15 Hypoxic-ischemic injury response to erythropoietin
pretreatment
GDS2937 NPCs 6 Olfactory marker protein deficiency effect on the
olfactory epithelium
GDS2846 Neuron 6 MicroRNA miR-124 expression effect on neuronal cell line
GDS2803 Neurogenesis 4 Fluoxetine effect on the hippocampus
GDS2391 Neurogenesis 6 PGC-1alpha transcriptional coactivator null mutation
GDS2096 Cancer cells 8 Glucocorticoid receptor activation effect on breast cancer
cells
GDS1793 Neuron 8 Homeodomain interacting protein kinase 2 dominant-negative form effect on trigeminal ganglion
GDS1693 CNS 39 Transcription factor Nrl deficiency effect on photoreceptor
development
GDS1635 Neuron 20 Nodose and dorsal root ganglia comparison
GDS1084 eNSCs 8 Homeobox Dlx1/2 mutations effect on embryonic
telencephalon
GSE13386 Neuron 24 Comparative analysis of Drd1+ Medium Spiny Neurons,
Drd2+ Medium Spiny Neurons, cocaine treatment
GSE13385 Neuron 9
GSE13384 Neuron 6
Zhang et al. BMC Systems Biology 2011, 5:152
http://www.biomedcentral.com/1752-0509/5/152
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significant. NSC-GN1 was further extracted to be a
sparser one, which is called NSC-GN2 (Figure 2B). It
contains nodes and edges with higher positive rate and
negative rate compared to nodes and edges in NSC-
GN1. 36 genes have significant relationship with
Table 1 62 mouse neural stem cell related microarray data sets included in the analysis. (Continued)
GSE13387 Neuron 24
GSE13394 CNS 63 A translational profiling approach for the molecular
characterization of CNS cell types
characterization of CNS cell types
GSE13379 CNS 107 Application of a translational profiling approach for the
comparative analysis of CNS cell
GSE11258 Neuron 24 Npas4-regulated genes in mouse hippocampal neurons
GSE10796 NPCs 4 Identification of genes that restrict astrocyte differentiation
of midgestational neural precursor cells
GSE11859 NPCs 27 Acquisition of granule neuron precursor identity and
Hedgehog-induced medulloblastoma in mice
GSE8034 Radial glia 17 Prospective isolation of functionally distinct radial glial
subtypes
GSE11207 Neuron 6 Dorsal root ganglion
GSE11141 NSCs 21 Effects of NgR overexpression on the developing and
mature forebrain
GSE10360 neuron 2 Role of Endothelin in SCG axon pathfinding
GSE9566 eNSCs 3 PDGF-B induces a homogeneous class of
oligodendrogliomas from embryonic neural progenitors
GSE9803 Neurogenesis 9 Striatal gene expression data from 12 weeks-old R6/2 mice
and control mice
GSE9804 Neurogenesis 9
GSE9330 Neurogenesis 8 Transcription factor Ctip2 deficiency effect on brain striata
GSE6540 Neurogenesis 12 Expression data from olfactory epithelium of Lip-C-treated
mice compared to Lip-O-treated control mice
GSE9443 CNS 131 Sleep deprivation and the brain
GSE6485 Neurogenesis 6 Expression data from olfactory epithelium of Harlequin
mutant mice compared to littermate controls
GSE9760 ESC 12 Embryonic stem cells with expanded CAG repeats
GSE6476 Neuron 4 Fluoxetine effect on the hippocampus
GSE8311 Neurogenesis 5 Dlx homeodomain transcription factor mutants
GSE8024 NSC, ESC 8 Murine ES cells, neural precursor cells and embryonic
fibroblasts
GSE4927 Neurogenesis 6 Olfactory marker protein deficiency effect on the olfactory
epithelium
GSE6275 CNS 36 neuronal dysfunction associated with the ataxic and epileptic
phenotypes
GSE4774 Development 15 To determine how Dlx homeobox genes function
GSE4752 CNS 6 target genes regulated by Egr transcriptional regulators
GSE4051 Diff. 8 Photoreceptor-specific nuclear receptor NR2E3 ectopic
expression effect on NRL null retinas
GSE4041 CNS 6 abnormal expression patterns in NR3B-null mice
GSE2873 Diff. 4 Skeletal muscle synaptic region
GSE2869 Neurogenesis 8 Homeodomain interacting protein kinase 2 dominant-
negative form effect on trigeminal ganglion
GSE2161 eNSCs 8 Homeobox Dlx1/2 mutations effect on embryonic
telencephalon
NPCs: Neural progenitor cells; eNSCs: Embryonic neural stem cells; MSCs: Mesenchimal stem cells; ESC: Embryonic stem cells; Diff.: Differentiation.
Zhang et al. BMC Systems Biology 2011, 5:152
http://www.biomedcentral.com/1752-0509/5/152
Page 6 of 12tmem59 and 46 significant regulatory relationships were
identified in NSC-GN2, of which the average node
degree is 1.2. Pou6f1 regulates 11 genes in NSC-GN2,
suggesting that it is the most important gene in it. Rnd3
and cds1 is related to 5 different genes, respectively. It is
worth to mention that, three genes are found to regulate
tmem59. In the other words, tmem59 is negatively
regulated by cd59a, while positively regulated by sncg
and myrip.B o t hcd59a and sncg were also found in
NSC-GN1.
Combined with published data, we constructed an inte-
grated network containing both gene regulations and pro-
tein-protein interactions with 68 nodes and 98 edges
(NSC-GN3 is illustrated in Figure 2C). The average node
degree of NSC-GN3 is 1.4. 39 genes, 29 encoded proteins,
66 regulatory relationships and 32 protein-protein interac-
tions are included in NSC-GN3. Partially, gene regulatory
relationships of mouse NSCs and differential mechanism
of NSCs in protein level is shown in NSC-GN3.
Novel regulatory pathways
We used the predicted regulatory network of mouse
NSCs to infer newly gene interactions. We transformed
the location of the nodes in NSC-GN2 and got NSC-
GN4 (Figure 2D). From NSC-GN4, four pathways which
is related to the expression of tmeme59 were obviously
identified as
Pou6f1-Cd59a-Tmem59,
Pou6f1-sncg-Tmem59,
Pou6f1-Wfdc2-Rnd3-Mgp-Myrip-Tmem59, and
Pou6f1-Wfdc2-Rnd3-Sncg-Tmem59.
All the four pathways initiated from the transcription
factor pou6f1. Moreover, the expression of tmem59 is
regulated directly by myrip, sncg and cd59a, all of which
are regulated by pou6f1 directly or indirectly.
A novel regulator, pou6f1, regulate the expression of
tmem59
From Figure 2D, pou6f1 is identified to be a dense node,
giving hint that pou6f1 may play an important role in
tmem59 expression. In order to confirm this supposition,
we constructed an expressional vector to over-express
Figure 1 The efficiency and speedup curves of the parallel SWNI algorithm. Both of the efficiency and speedup are calculated on two
samples. One is an network of 1000 nodes and the other is an network of 1500. (A) Efficiency of the algorithm draw dramatically when
processors increased from one to four and then tend to stable. (B) The Speedup is close to a straight line with network of 1500 nodes
compared to the network of 1000 nodes.
Table 2 Computing time of the parallel SWNI algorithm
for two types of networks on increased processors.
Number of
processors
Network of 1000
nodes
Network of 1500
nodes
1 6501.85 48102.6
2 3670.23 24528.4
4 2193.08 12528.7
6 1485.62 8457.89
8 1122.75 6405.23
10 908.12 5139.61
12 769.32 4280.88
14 666.19 3685.25
16 588.23 3254.62
18 525.86 2887.79
20 479.17 2621.81
22 439.52 2399.3
24 406.73 2217.95
26 383.95 2054
28 357.58 1921.4
30 338.8 1780.58
32 322.09 1689.94
We simulated two types of artificial gene networks in size of 1000 nodes,
3054 edges, and 1500 nodes, 4630500 edges, respectively, to assess the
performance of the parallelized SWNI algorithm. The computing time is
calculated. The results show that as increase in the processors number, the
computing time of the algorithm falls dramatically. The study suggested that
the parallelized SWNI algorithm has good performance on the artificial gene
networks.
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N2-POU6F1) for real-time observation and quantification
in C17.2 NSCs. The results suggested that, POU6F1, a
transcription factor, was expressed successfully in the
nucleus of NSC compared with ubiquitous location of
EGFP (Figure 3A, B, C, D). C17.2 NSCs transfected with
pEGFP-N2 vector were used as a control group. Statisti-
cally, C17.2 NSCs showed 37.06% ± 4.31% (P < 0.01)
increase in tmem59 expression caused by the overexpres-
sion of pou6f1 (Figure 3E). This study firstly identifies a
regulator pou6f1 that may account for tmem59 expression.
Localization of tmem59 related genes and identification
of functional-related gene groups
In NSC-GN2 (Figure 2B), 36 genes were predicted to be
related to tmem59 and 27 of them are annotated in Gene
Ontology (GO). Among the 27 annotated proteins, 4, 1, 2
and 4 proteins are localized on plasma, membrane,
nucleus and extracellular, respectively. Figure 4 illustrates
that 10.8%, 6.0%, 5.4% and 10.8% of all the 37 proteins in
NSC-GN2 are localized on different sites, except 27% un-
annotated ones.
As mentioned above, the novel membrane proteinT-
MEM59 modulates complex glycosylation. Based on GO
annotation, there are 42% of the 37 proteins involved in
metabolism including TMEM59 (Table 3), suggesting that
most of the genes have functional similarity with tmem59.
Beyond that, more than 20% of the 37 proteins are
reported to transport materials within cells. The analysis of
tmem59 related GRN of mouse NSCs highlights new can-
didate genes involved in (i) peptidase activity, hydrolase
activity, kinase activity, and transferase activity; (ii) trans-
portation of water, lipid and metal ion; (iii) protein binding;
(iv) transcription process.
Identification of Alzheimer’s disease related genes
It is interesting to address how many genes in tmem59-
related GRN (NSC-GN2) could be related to Alzheimer’s
Figure 2 Predicted gene regulatory networks related to tmem59. (A) NSC-GN1 is predicted to be a network of 56 genes and 230 edges. (B)
NSC-GN2 is predicted to be a network of 37 genes and 46 regulations. (C) NSC-GN3 is identified as a combined network of 39 genes and 29
proteins with 66 regulations and 32 protein-protein interactions. Dark nodes are genes, while light nodes are proteins. (D) NSC-GN4 is extracted
from (B) to focus on the precise pathways directed to tmem59 from pou6f1.
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Page 8 of 12disease (AD). Epigenetic profiling reveals that TMEM59
was down-regulated and lower methylated in major phy-
chosis [34]. And the maturation and localization of amy-
loid precursor protein (APP) is reported to be modulated
by TMEM59 [35]. APP is crucial during the AD patho-
genesis, which is often accompanied by some psychotic
diseases. In NSC-GN2, Cd59a, myrip and sncg are the
three genes which directly regulate tmem59,a n dh a v e
been proved to be AD-related in previous reports. In
NSC-GN2, our study showed that 17 out of 37 predicted
genes (including tmem59)a r er e l a t e dt oA Di nN S C -
GN2: Ace [36], aqp1 [37], arrdc3 [38], cd14 [39], cd59a
[40], cds1 [41], cldn1 [42], cox8b [43], defb11 [44], folr1
[45], gdi2 [46], mmp3 [47], mgp [48], myrip [49], Ripk4
[50], rnd3 [51,52], and sncg [53]. Among them, Cd59a,
myrip and sncg regulate tmem59 directly.
Discussion
Tmem59 has been reported to sustain the status of
NSCs in vitro. Knockout of tmem59 in mouse brain can
induce expressional changes of 627 genes in neonatal
mouse NSCs. Until now, the underlying function of
tmem59, especially on the differentiation of mouse
NSCs, is still unclear. In this study, we try to find out
regulators likely to affect theg e n ee x p r e s s i o ni nm o u s e
NSC and new mechanism of neurodegeneration in AD
from a compendium of expression profiles.
Firstly, 36 genes were identified to be tmem59 related.
In the predicted network NSC-GN2, tmem59 is regu-
lated directly by cd59a, myrip and sncg. Meanwhile, four
pathways were found in NSC-GN2 to regulate the
expression of tmem59 from pou6f1. Tmem59 is located
downstream in all the pathways, indicating that tmem59
Figure 3 Positive regulation of pou6f1 to tmem59 is evident in C17.2 NSCs. (A, B) gray photos were captured in white light. (C, D)POU6F1-
EGFP (green) was over-expressed in the nucleus of C17.2 neural stem cells. Photography was captured at 36-hours after transfection of pEGFP-
N2-Pou6f1 plasmid. (E) Real-time PCR showed that tmem59 is up-regulated by over-expression of pou6f1 (normalized to b-actin). N = 3, **P <
0.01. OE: over-expression of POU6F1-EGFP; Con: control group transfected with pEGFP-N2.
Figure 4 Location of proteins in Tmem59-related regulatory network. (A) Distribution of proteins in sub-cellular level. Most of the proteins
were located in membrane. (B) Non-Plasma proteins (located in membrane, nucleus and extra-cell) were significantly more than in plasma.
Unknown: no notation information in Genebank; ***p < 0.001.
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Page 9 of 12is probably regulated by all the other genes. These con-
clusions are in accordance with observations from ear-
lier studies [23]. Our study suggests that the 36 genes
probably act on the differentiation of NSCs and have
similar function with tmem59.
Secondly, Our RT PCR analysis results shown that
tmem59 is positively regulated by pou6f1.A n dpou6f1
has been reported to play an important role during the
development of mouse telencephalon [54]. Our study
suggests that the influence of pou6f1 on mouse telence-
phalon development is originated from the effect on
NSCs during the mouse embryonic development. This
study provides further insights into the role of the dif-
ferentiation of NSCs.
Thirdly, our study suggests that TMEM59 has similar
localization with most of its regulators. Recently,
TMEM59 was reported to be a Golgi-localized protein,
which is crucial in modulated complex glycosylation, cell
surface expression and secretion of amyloid precursor
protein [34]. As known, proteins in the cell plasma are
synthesized directly in free ribosome, while some other
membrane proteins which transfer to the nucleus, are
synthesized in rough endoplasmic reticulum. The second
type of protein will be transported to subcellular location
secreted by Golgi-complex. Among the 27 annotated
genes in the predicted network NSC-GN2, more than
85% were identified to be nonplasmic localized. This sug-
gests that 85% of the 27 proteins are Golgi-localized in
maturation and has similar localization with TMEM59.
Furthermore, our study suggests that the tmem59
related gene regulatory network (NSC-GN2) is probably
AD-related. As the precursor of b-amyloid protein (Ab),
b-amyloid precursor protein (APP) is addressed to be
t h ef i r s tg e n e t i cm u t a t i o n .T h ed e p o s i t i o no fA b in pla-
ques of brain is already identified to be the cause of AD.
As been reported, TMEM59 is Golgi-localized in
Hek293 cell line, and modulate the complex glycosyla-
tion, cell surface expression and secretion of APP. The
s t u d yi n d i c a t e st h a tT M E M 5 9m a yb ea s s o c i a t e dw i t h
AD. In our predicted mouse NSCs related network
NSC-GN2, three genes which regulate Tmem59 directly
are identified as sncg, cd59a and myrip. Sncg (g-synu-
clein) has been identified to be correlated to dementia
hippocampus of AD and pathology of Parkinson’sd i s -
ease (PD) [55]. Deficiency of complement regulator
cd59a is the cause of neurodegeneration in AD [56].
And Rab27 binding protein MYRIP is involved in insu-
lin exocytosis, impaired which is the pathogenesis of AD
[57,58]. Besides, there are nearly 50% of all the genes in
NSC-GN2 have been reportedt ob ed i r e c t l yo ri n d i r -
ectly related to AD. Therefore, tmem59, which directly
regulated by cd59a, myrip and sncgis, is suggested to be
associated with AD, and the unreported genes in NSC-
GN2 are probably related to AD either.
Conclusions
In this study, we predicted the mouse NSCs related
GRNs by the parallelized SWNI algorithm integrating
data from the tmem59 knock out microarray datasets
Table 3 Function of the 37 differentially expressed genes
identified in Figure NSC-GN2.
Function Number of
genes
Go accession
numbers
Entrez Gene
Enzymatic
activity
12 GO:0016787 Ace
GO:0016740 Cd14
GO:0016740 Cds1
GO:0016491 Cox8b
GO:0005097 Gdi2
GO:0008237 Mmp3
GO:0017137 Myrip
GO:0016301 Nek5
GO:0016787 Ptprv
GO:0016301 Ripk4
GO:0004867 Tmem59
GO:0004867 Wfdc2
Transporter
activity
6 GO:0015250 Aqp1
GO:0046872 Cyb561
GO:0008517 Folr1
GO:0005509 Mgp
GO:0005319 Saa3
GO:0005328 Slc6a13
Protein binding 5 GO:0034235 Cd59a
GO:0016338 Cldn1
GO:0005178 Gpnmb
GO:0004872 Paqr9
GO:0070192 Rec8
Molecular
function
4 GO:0003674 Arrdc3
GO:0003700 Pou6f1
GO:0000166 Rnd3
GO:0003674 Sncg
Cytoskeleton 1 GO:0007010 Krt8
Unknown 9 None 1110059m19Rik
None 2900017f05Rik
None Axud1
None Calm14
None C230095g01Rik
None Defb11
None S3-12
None Slc35f3
None Tinag1
Based on the GO annotation, the function of the 37 genes in NSC GN2 is
classified. The function, number and Entrez Gene in Genbank are listed as
follows. There are 42% proteins having the function of metabolism including
TMEM59 in GO-known proteins. Except that, more than 20% proteins function
on transporting materials for cells.
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Page 10 of 12and 62 mouse stem cell related microarray datasets in
GEO. The parallelized SWNI algorithm increased the
efficiency of network reconstruction significantly. In par-
ticular, a high confident network of mouse NSCs (NSC-
GN2) was predicted. In the network, 36 key genes regu-
lating tmem59 expression were identified. The RT PCR
result suggested that tmem59 can be positively regulated
by pou6f1 significantly. Moreover, 17 out of 36 genes
are predicted to be AD related in our network including
tmem59. This is in coherence with published references.
This present work provides new insights regarding the
gene regulations of NSCs. The parallel methods pre-
sented in this paper might also become a scalable tool
for large-scale analysis on various types of cells and spe-
cies. And integration of multiple datasets will provide
for new research directions in microarray analysis. This
study enables us to highlight novel genes that may be
involved in NSC differentiation and provides a shortcut
to identify genes for AD.
Additional material
Additional file 1: Table S1 for 80 selected genes lists from the
tmem59 knock-out microarray experiment included in the analysis.
From the tmem59 knock out microarray datasets, 627 genes that
differentially expressed with more than 2-fold change were selected as
our source of data. In order to focus on much significantly expressed
genes related to tmem59, we selected 80 genes for further analysis
based on the Differential Ratio following tmem59 knock out. The symbol,
Gene ID and function of each gene can be searched in Genbank.
Additional file 2: Table S2 for 21 platforms related to 146
microarray datasets about mouse NSCs. Microarrays about NSCs,
neurogenesis, glias and central nervous system (CNS) are selected, due to
that NSCs are the principal source of constitutive neurogenesis and glias
in the CNS. 146 microarray datasets were selected from 21 different
platforms for constructing genes regulatory network of mouse NSC. The
species, accession numbers, precise descriptions and number of data sets
of the 21 platforms are illustrated.
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